Amir Nashat
@amirnashat
Director
Building FATE THERAPEUTICS INC as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Metacrine, Inc. was founded in 2014 and has no closure on record.
Named alongside
- ALFICA SEHGALExecutive Officer
- Andrew J. SchwabDirector
- ANDY SCHWABDirector
- ANN BARBIERExecutive Officer
- CALEB MOOREExecutive Officer
- DAVID BUMCROTExecutive Officer
- JAMES J. BOYLANDirector
- JORGE CONDEDirector
- AMIR S. NASHATDirector
- CHRIS D. STORGARDExecutive Officer
- Christian WeyerExecutive Officer, Director
- CINDY D. TAHLExecutive Officer
- Cindy TahlExecutive Officer
- DANIEL D. SHOEMAKERExecutive Officer
- Daniel ShoemakerExecutive Officer
- John MendleinDirector
- Charles RobertsDirector
- Ellen HukkelhovenDirector
- Gabriel OtteExecutive Officer, Director
- Michael NolanExecutive Officer, Director
- Peter KolchinskyDirector
- Randal ScottDirector
- Riley EnnisExecutive Officer, Director
- Vijay PandeDirector
- Carol GallagherDirector
- Jackie HernandezExecutive Officer
- Kenneth SongExecutive Officer, Director
- Ken SongExecutive Officer, Director
- Kristina BurowDirector
- Neil McDonnellExecutive Officer, Director
- Patricia MillicanExecutive Officer
- Richard HeymanDirector
Contribution
Amir's ideas, decisions and failures appear here once this profile is claimed.
Companies
- FATE THERAPEUTICS INCBiological Products, (No Diagnostic Substances); listed on Nasdaq as FATE; filing with the SEC since 2008Director · Biotechnology · SAN DIEGO, United States
- Metacrine, Inc.Pharmaceutical Preparations; filing with the SEC since 2015Director · Pharmaceuticals · SAN DIEGO, United States · Founded 2014
- Scholar Rock LLCDirector · Biotechnology · CAMBRIDGE, United States · Founded 2012
- Sofregen Medical Inc.Director · Biotechnology · Medford, United States · Founded 2014
- Syros Pharmaceuticals, Inc.Pharmaceutical Preparations; formerly LS22, Inc.; filing with the SEC since 2012Director · Biotechnology · CAMBRIDGE, United States
- Camp4 Therapeutics CorpPharmaceutical Preparations; listed on Nasdaq as CAMP; filing with the SEC since 2018Director · Biotechnology · CAMBRIDGE, United States · Founded 2015
- Morphic Holding, LLCPharmaceutical Preparations; formerly Morphic Holding, LLC; filing with the SEC since 2016Director · Biotechnology · WALTHAM, United States · Founded 2014
- Freenome Holdings, Inc.Services-Medical Laboratories; filing with the SEC since 2016Director · Services-Medical Laboratories · PHILADELPHIA, United States · Founded 2016